| Closed |
S9720 |
ENDOMETRIAL |
2/15/1998 |
7/15/2000 |
100% |
|
Published
|
| Closed |
S9632 |
Enhancing Well-Being During Breast Cancer Recurrence |
6/1/1997 |
8/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-9314 |
ER and PgR Predicting Response to Tamoxifen |
9/1/1993 |
12/15/1995 |
91% |
|
Published
|
| Closed |
S0101 |
ESOPHAGEAL |
4/15/2001 |
2/1/2003 |
100% |
|
Published
|
| Closed |
S0356 |
ESOPHAGEAL |
9/15/2004 |
8/1/2008 |
100% |
|
Published
|
| Closed |
S0415 |
ESOPHAGEAL |
10/15/2004 |
1/1/2007 |
100% |
|
Published
|
| Closed |
S0414 |
ESOPHAGEAL |
5/1/2005 |
9/1/2007 |
29% |
|
Published
|
| Closed |
SWOG-9046 |
Evaluation of 10-EdAM in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II |
12/15/1990 |
4/1/1992 |
100% |
|
Published
|
| Closed |
SWOG-8303 |
Evaluation of 2'Deoxycoformycin in Refractory Multiple Myeloma TEMPORARILY CLOSED: 8/17/84 |
4/25/1983 |
3/22/1985 |
|
|
Published
|
| Closed |
SWOG-9122 |
Evaluation of 5-Fluorouracil By Intermittent Infusion in Combination with Alpha-Interferon for Patients with Advanced Renal Cell Carcinoma, Phase II |
6/1/1992 |
10/15/1993 |
100% |
|
Published
|
| Closed |
SWOG-8604 |
Evaluation of 6-Thioguanine (6-TG)(NSC-752) in Refractory and Relapsing Myeloma |
10/15/1986 |
12/1/1987 |
|
|
Published
|
| Closed |
SWOG-9062 |
Evaluation of 96 Hour Infusion 5-FU + Cisplatin + Alpha Interferon in Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II |
8/1/1991 |
10/1/1993 |
100% |
|
Published
|
| Closed |
SWOG-8262 |
Evaluation of Aclacinomycin A in Adult Acute Leukemia |
4/26/1982 |
12/5/1983 |
|
|
Published
|
| Closed |
SWOG-8213 |
Evaluation of Aclacinomycin A in Refractory Multiple Myeloma TEMPORARILY CLOSED: 3/22/85 |
7/21/1982 |
9/27/1985 |
|
|
Published
|
| Closed |
SWOG-9223 |
Evaluation of Alpha Interferon/All Trans-Retinoic Acid in Disseminated Malignant Melanoma, Phase II |
10/1/1993 |
8/15/1995 |
100% |
|
Published
|
| Closed |
SWOG-9132 |
Evaluation of Alpha Interferon/Isotretinoin or Alpha Interferon/All Trans Retinoic Acid in Cervical Cancer, Phase II |
9/15/1992 |
5/15/1996 |
100% |
|
Published
|
| Closed |
SWOG-8717 |
Evaluation of Amonafide and Didemnin-B in the Treatment of Ovarian Cancer |
5/15/1988 |
|
63% |
|
Published
|
| Closed |
SWOG-8722 |
Evaluation of Amonafide in Adenocarcinoma of the Prostate |
11/1/1987 |
4/1/1989 |
|
|
Published
|
| Closed |
SWOG-8715 |
Evaluation of Amonafide in Advanced Sarcomas |
3/1/1988 |
2/1/1990 |
|
|
Published
|
| Closed |
SWOG-8725 |
Evaluation of Amonafide in Cervical Cancer |
12/1/1988 |
12/1/1990 |
|
|
Published
|
